I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Drug-Induced Uveitis: Causes, Symptoms, and Treatment
What Is Drug-Induced Uveitis?
Uveitis is a term for inflammation inside the eye, specifically within the uvea, the middle layer of the eye that contains most of its blood vessels. When this inflammation is triggered by a medication rather than an infection or immune condition, it is called drug-induced uveitis. Identifying the responsible drug is central to getting the right treatment.
The uvea consists of three connected parts: the iris (the colored ring around your pupil), the ciliary body (which helps the eye focus), and the choroid (a dense layer of blood vessels that sits behind the retina). Because the uvea is so rich in blood vessels, inflammation in this area can spread quickly and affect the eye's ability to function.
Uveitis is classified by where the inflammation is most concentrated. Anterior uveitis affects the front of the eye, intermediate uveitis involves the middle zone, posterior uveitis involves the back of the eye near the retina, and panuveitis involves all layers at once.
The exact mechanisms behind drug-induced uveitis are not fully understood, but researchers have identified two broad categories of effects: direct and indirect.
- Direct effects occur when a drug reaches the inside of the eye through eye drops, injections, or surgery. The drug itself, a chemical byproduct, or even an inactive ingredient may have a toxic effect on eye tissue, disrupting the blood-ocular barrier that normally shields the eye's interior.
- Indirect effects occur when medications taken by mouth or given intravenously trigger an immune response. The drug can cause antibodies to form and accumulate in uveal tissue, releasing inflammatory chemicals that damage the eye.
- Some drugs bind to melanin, the pigment found in the iris and other eye structures. This binding can provoke inflammation and reduce melanin's ability to neutralize harmful molecules.
- Certain antibiotics work by killing microorganisms rapidly, which releases substances that can trigger an immune reaction inside the eye.
Drug-induced uveitis is uncommon. It accounts for less than half of one percent of uveitis cases seen at major referral centers. However, because many cases go unrecognized or are attributed to other causes, the true number may be higher than reported.
Not every person who takes a medication linked to uveitis will develop the condition. Individual risk varies depending on genetics, the dose being taken, and whether other medications are being used at the same time.
Who Is Most at Risk?
Drug-induced uveitis can affect anyone taking a medication that has been associated with eye inflammation. Certain individual characteristics can make a reaction more likely, and understanding these risk factors helps both patients and care teams stay appropriately alert. Risk is shaped by the medication itself, the dose, and the person taking it.
Higher medication doses, lower body weight, and taking multiple drugs simultaneously can all increase the likelihood of a reaction. The way a drug is administered also matters. Medications given directly into the eye (intravitreal injections) or by IV may have different risk profiles than those taken by mouth.
Genetics can play a meaningful role in susceptibility. Among patients who developed uveitis after taking fluoroquinolone antibiotics, a genetic marker called HLA-B27 was identified in roughly 20% of those tested, and the HLA-B51 marker was found in approximately 40%. Both markers are associated with a higher baseline tendency toward inflammatory conditions.
Women appear to be affected more often than men in certain medication categories. In a review of fluoroquinolone-related cases, nearly 70% of patients were women, with a median age in the mid-50s. These patterns may reflect differences in how certain drugs are metabolized in the body.
Rates of drug-induced uveitis also vary across racial groups for some medications. The reasons are not entirely clear, but they may relate to differences in melanin content within the eye and how strongly certain drugs bind to it.
Certain medications have well-documented associations with uveitis. The antiviral drug cidofovir causes a form of anterior uveitis in a large majority of patients who receive it and in some cases also causes abnormally low eye pressure, a condition called hypotony. The antibiotic rifabutin carries elevated risk at doses of 600 mg or more per day, particularly in patients with low body weight or those taking certain other drugs at the same time.
Cancer immunotherapy drugs, including immune checkpoint inhibitors and related targeted therapies, are an increasingly recognized source of drug-associated uveitis. A significant proportion of patients receiving these treatments for melanoma develop eye-related side effects.
Recognizing the Symptoms
The symptoms of drug-induced uveitis closely resemble those of other forms of eye inflammation, which is one reason the diagnosis can be delayed or missed. Being aware of what to look for, especially after starting a new medication, is important for getting timely care. Some drugs also produce recognizable patterns of inflammation that can help a specialist pinpoint the cause.
The most common symptoms include eye pain, sensitivity to light (photophobia), blurred vision, and redness. These may develop in one or both eyes. Severity ranges from mild discomfort and subtle blurriness to significant pain and noticeable changes in vision.
The time between starting a medication and developing symptoms can range from a few hours to several months. How a drug is given plays a role in this timing. Medications administered by IV may cause symptoms within hours, while those taken by mouth may take several days or longer to trigger a response.
In cases linked to fluoroquinolone antibiotics, the average time from starting the medication to developing symptoms is approximately 13 days, though reactions have been reported nearly immediately and as late as about three weeks after starting treatment.
Some medications produce distinctive clinical findings that help a retina specialist identify the cause of inflammation. Fluoroquinolone-induced uveitis, for example, is associated with three characteristic findings that may be observed during an examination.
- Pigmented deposits on the inner surface of the cornea (called keratic precipitates), often accompanied by elevated eye pressure
- Areas on the iris where pigment has been lost, allowing light to pass through abnormally (known as iris transillumination defects)
- Pupils that respond sluggishly or not at all to light (atonic pupils)
Identifying these patterns helps distinguish a drug-related cause from other types of uveitis and guides both the diagnosis and the treatment approach.
How Drug-Induced Uveitis Is Diagnosed
There is no single test that can confirm drug-induced uveitis. Reaching the correct diagnosis requires a careful eye examination, a thorough review of your medication history, and ruling out other potential causes. The timing of symptoms in relation to when you started a new medication is often the most important clue available to your specialist.
Many different conditions can cause uveitis, including infections and autoimmune diseases. Because individual responses to the same medication can vary significantly, drug-induced cases are not always immediately obvious. The diagnosis is reached by systematically ruling out other explanations rather than through a single confirming test.
A retina specialist will use a slit lamp, a microscope with a focused light source, to examine the interior of the eye in detail. This allows the specialist to look for cells and protein floating in the fluid at the front of the eye (signs of active inflammation), changes to the iris, and any deposits on the cornea.
When inflammation involves the back of the eye, additional imaging is needed. OCT (optical coherence tomography), a scan that produces detailed cross-sectional images of the retina, can reveal swelling or structural damage. Fluorescein angiography, a test that uses a dye to photograph blood flow in the retina, may also be performed to assess the extent of involvement.
A detailed review of all current and recent medications is essential. Your specialist will look for drugs known to be associated with uveitis and assess whether the timeline of your symptoms corresponds with when you began taking them. Blood tests and other evaluations are used to rule out infections and autoimmune conditions. A drug-induced cause can be confirmed only after other explanations have been excluded.
Treatment Approaches
Treating drug-induced uveitis begins with identifying the responsible medication and, when safely possible, stopping it. From there, the focus shifts to reducing inflammation and protecting vision. Your retina specialist will develop a treatment plan based on the severity of the inflammation, which part of the eye is affected, and your overall medical situation.
Discontinuing the offending drug is the single most important step in treatment. In many cases, stopping the medication alone leads to resolution of the inflammation within a few weeks. When that drug is essential for treating a serious underlying condition, your retina specialist will work with your prescribing physician to explore alternatives that carry less risk to the eye.
For inflammation at the front of the eye, corticosteroid eye drops are the standard initial treatment. These drops reduce inflammation inside the eye and help prevent complications from developing. The dosing frequency depends on the severity of inflammation, and your specialist will create a tapering schedule that gradually reduces the drops as the eye heals.
Cycloplegic or mydriatic drops (medications that dilate the pupil and relax the ciliary muscle) are often prescribed alongside corticosteroids. These help ease pain and prevent the iris from forming adhesions to the lens, a complication known as posterior synechiae.
If inflammation is severe, involves the back of the eye, or does not improve with eye drops alone, oral or injected corticosteroids may be necessary. In rare cases where inflammation persists despite stopping the offending drug and using steroids, your care team may consider additional anti-inflammatory treatments based on the specific situation.
Some forms of drug-induced uveitis raise eye pressure, while others cause it to drop abnormally low (hypotony). Both extremes can cause lasting damage to vision. Your retina specialist will monitor pressure closely throughout your treatment and prescribe additional drops if adjustments are needed to keep it within a safe range.
Recovery and What to Expect
Most patients with drug-induced uveitis recover well once the responsible medication is identified and appropriate treatment is started. The course of recovery depends on how quickly the condition was recognized, how severe the inflammation was, and which part of the eye was involved. Consistent follow-up care plays an important role in making sure recovery proceeds as expected.
Mild cases often resolve within one to two weeks after stopping the medication and beginning treatment. More severe cases may take several weeks to months for inflammation to fully clear. Vision generally improves as inflammation comes under control, though complete recovery depends in part on how much damage occurred before treatment began.
Scheduled follow-up appointments allow your retina specialist to track inflammation levels, monitor eye pressure, and identify any complications early. Even after the eye appears to have recovered, one or two additional visits are typically recommended to confirm that the inflammation has not returned before treatment is fully discontinued.
When drug-induced uveitis is not caught and treated in a timely way, it can lead to lasting problems. These may include elevated eye pressure or glaucoma (a condition that damages the optic nerve), cataract formation (clouding of the natural lens), and macular edema (swelling in the central retina that can impair central vision).
In severe or prolonged cases, significant and permanent vision loss may occur. With timely identification and treatment, however, most patients avoid serious long-term effects.
The overall prognosis for drug-induced uveitis is generally favorable. Once the responsible medication is removed and inflammation resolves, recurrence is unlikely as long as the same drug or a closely related one is avoided. Most patients have no underlying predisposition to uveitis and do not experience the condition again unless re-exposed to a triggering medication.
Living with Drug-Induced Uveitis
Recovering from drug-induced uveitis involves more than treating the immediate inflammation. Going forward, clear communication with all of your healthcare providers and staying informed about which medications carry risk are both important parts of protecting your eye health. A few proactive steps can meaningfully reduce the chance of a future episode.
Let all of your healthcare providers know about your experience with drug-induced uveitis, including your primary care physician, any specialists, and your pharmacist. Keep a specific record of the medication that caused the reaction. This information helps every provider involved in your care avoid prescribing the same drug or closely related ones in the future.
Before starting any new medication or supplement, mention your history. Your providers can weigh alternatives or arrange closer monitoring if a higher-risk drug is genuinely necessary for your health.
Many different types of medications have been linked to uveitis. Being familiar with the main categories can help you stay alert after starting something new and know when to contact a specialist.
- Topical eye medications: prostaglandin analogs used for glaucoma, metipranolol, brimonidine, and certain corticosteroid preparations
- Systemic antibiotics: fluoroquinolones (particularly moxifloxacin), rifabutin, and sulfonamides
- Bisphosphonates (medications used for bone density), certain diuretics, and some medications used for skin conditions
- Cancer immunotherapy drugs: immune checkpoint inhibitors, BRAF inhibitors, and MEK inhibitors
- Medications injected directly into the eye (intravitreal): cidofovir and certain biologic agents
- Vaccines: rare cases of uveitis have been reported following some vaccinations
This list covers the most commonly reported categories and is not exhaustive. If you develop eye symptoms after starting any new medication, reaching out to a retina specialist for evaluation is always the right step.
When to Seek Care
Knowing when to seek care urgently versus scheduling a routine visit can make a significant difference in protecting your vision. Some symptoms require immediate attention, while others can be addressed through a planned appointment. When you are unsure, contacting a specialist promptly is always the safest choice.
Seek care right away if you experience any of the following, especially if they develop after starting a new medication.
- Sudden or significant loss of vision in one or both eyes
- A shadow, dark spot, or curtain across any part of your vision
- A sudden increase in floaters (spots, strings, or clouds drifting through your field of view)
- Flashes of light
- Severe eye pain, redness, or sensitivity to light
These symptoms may also indicate other serious retinal conditions that require emergency evaluation and should never be ignored or observed at home.
If you are taking a medication with a known association with uveitis, speak with your retina specialist about whether scheduled eye examinations make sense for your situation. Patients on long-term therapy with high-risk drugs, such as cancer immunotherapy agents or cidofovir, may benefit from periodic monitoring even before symptoms develop.
Detecting low-level inflammation before it produces noticeable symptoms gives your care team the best opportunity to intervene early and prevent more significant damage.
Frequently Asked Questions
Below are answers to questions we hear often from patients dealing with drug-induced uveitis, along with practical guidance for navigating treatment and follow-up care.
Most documented cases involve prescription drugs, but over-the-counter products and dietary supplements have been linked to rare cases of eye inflammation as well. If you notice eye pain, redness, or blurred vision after starting any new product, including herbal or nutritional supplements, schedule an evaluation with a retina specialist rather than waiting to see if symptoms resolve on their own. Prompt evaluation ensures that other serious causes are not overlooked in the process.
For the vast majority of patients, treatment with eye drops is temporary. Once the offending medication is discontinued and inflammation resolves, corticosteroid and cycloplegic drops are gradually tapered and then stopped. Long-term or permanent use of these drops is not typically required after a drug-induced episode. Your specialist will monitor your recovery and guide the tapering process based on how your eye responds over time.
The answer depends on the specific drug and the class it belongs to. In some cases, another medication within the same class may be well tolerated, while in others, shared chemical properties may carry a similar risk. This decision should involve both your retina specialist and the physician who originally prescribed the medication. If a switch is made, closer monitoring during the early weeks of therapy is advisable to catch any early signs of inflammation before they progress.
Timing is the most reliable clue. Eye pain, redness, or blurred vision that develop within days to weeks of starting a new medication should raise the question of a drug-related cause. However, only a thorough examination by a retina specialist can confirm the diagnosis. Infections, autoimmune diseases, and other conditions can produce identical symptoms, and ruling those out is a necessary part of the diagnostic process. Do not delay seeking care while trying to determine the cause on your own.
This situation arises most often in patients being treated for serious conditions such as cancer or certain systemic infections. In these cases, your retina specialist will work closely with your treating physician to weigh the continued use of the drug against the risk to your vision. Inflammation can often be managed with additional medications while you remain on the offending drug, but more frequent monitoring will be needed. Protecting your eye health in this setting requires close coordination across your entire medical team.
Expert Retinal Care at New England Retina Associates
At New England Retina Associates, our fellowship-trained vitreoretinal specialists have extensive experience diagnosing and managing complex forms of uveitis, including cases that are medication-related. We serve patients across Connecticut from four convenient office locations and welcome both physician-referred patients and those who reach out to us directly. If you are experiencing symptoms that concern you, or if you have been referred by your eye care provider, our team is here to help you understand your condition and explore the most appropriate path forward for your vision and your health.
30 Years of Care & Commitment
